The CDC’s non-test strategy recommends that COVID-19 patients discontinue self-isolation when they have not had a fever for 72 hours without the use of medications; have shown improvement in respiratory symptoms; and have gone at least 10 days since the start of symptoms, the researchers wrote in the letter.
The test-based strategy makes the same recommendations as the symptom-based strategy, but also recommends that the patient have two consecutive negative COVID-19 tests, conducted more than 24 hours apart, before discontinuing isolation.
The researchers assessed both strategies among COVID-19 patients at Mayo’s COVID Virtual Clinic in Jacksonville, Fla.
Of 92 patients studied, 72 patients met the criteria for release from self-isolation using the non-test strategy. They were all tested, and researchers found that a majority of the patients (69.9 percent) tested positive for the new coronavirus.
“This data shows that the CDC non-test-based strategy may cause early release from isolation for COVID-19 patients and result in additional community transmission,” the researchers wrote.
More articles on infection control:
Shortage of protective gear leads hospitals to buy and keep faulty N95 masks
Policies at Pennsylvania hospitals endangered patients, staff, whistleblowers say
Extended use of N95s is safer than reuse, ECRI suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
